Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 607 | 504 | 486 | 132 | 473 |
| Operating Income | -607 | -504 | -486 | -132 | -473 |
| Other Income | 118 | 62 | 8 | 0 | 1 |
| Pre-tax Income | -489 | -442 | -478 | -132 | -472 |
| Net Income Continuous | -492 | -442 | -478 | -132 | -475 |
| Net Income | $-492 | $-442 | $-478 | $-132 | $-475 |
| EPS Basic Total Ops | -0.03 | -0.03 | -0.04 | -0.01 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.03 | -0.04 | -0.01 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.03 | -0.04 | -0.01 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.03 | -0.04 | -0.01 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.03 | -0.04 | N/A | N/A |
| EBITDA(a) | $-607 | $-504 | $-486 | $-132 | $-473 |